Billiontoone (NASDAQ:BLLN) Sees Large Volume Increase on Better-Than-Expected Earnings

Billiontoone, Inc. (NASDAQ:BLLN) shares saw an uptick in trading volume on Thursday following a stronger than expected earnings report. 713,533 shares traded hands during mid-day trading, an increase of 179% from the previous session’s volume of 255,680 shares.The stock last traded at $72.51 and had previously closed at $80.83.

The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.07. The company had revenue of $96.05 million during the quarter, compared to the consensus estimate of $85.85 million. The firm’s quarterly revenue was up 113.0% compared to the same quarter last year.

Trending Headlines about Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q4 results beat expectations: reported EPS $0.11 vs. $0.04 est. and revenue $96.05M vs. $85.85M est.; revenue +113% YoY — a clear operational beat that supports the company’s growth story. BillionToOne Reports Fourth Quarter and Full Year 2025 Results
• Positive Sentiment: Company raised FY2026 revenue guidance to $430M–$445M (vs. Street consensus ~ $356M), which materially increases revenue expectations for the year and validates management’s forward outlook. Guidance Raise
• Positive Sentiment: Guggenheim reaffirmed a “buy” rating with a $120 price target, signaling some institutional confidence in the post-earnings outlook. Guggenheim Reaffirmation
• Neutral Sentiment: BTIG cut its price target from $160 to $140 but kept a “buy” rating — a mixed signal (lower target, rating intact) that tempers but doesn’t reverse bullish analyst sentiment. BTIG PT Lowered
• Neutral Sentiment: Market coverage and media pieces (earnings highlights, slide deck, conference call) provide additional color on growth drivers and margin trajectory for analysts and investors to reassess positions. Earnings Call Highlights
• Neutral Sentiment: Commentary pieces reviewing key metrics versus estimates are circulating; these help quantify the beat and will inform model revisions but are not new company data. Zacks Analysis
• Neutral Sentiment: Reported short-interest figures in some feeds look inconsistent/invalid (zeros/NaNs) and shouldn’t be relied on as a driver without cleaner data. (Keep an eye for accurate short-interest updates.)
• Negative Sentiment: Wells Fargo lowered its price target from $110 to $90 and moved to an “equal weight” rating — a bearish signal that likely pressured the stock after the earnings pop. Wells Fargo PT Cut

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Zacks Research upgraded shares of Billiontoone to a “hold” rating in a report on Tuesday, December 2nd. William Blair began coverage on Billiontoone in a research note on Monday, December 1st. They issued an “outperform” rating on the stock. Weiss Ratings began coverage on Billiontoone in a research report on Tuesday, February 3rd. They set a “sell (d)” rating for the company. Piper Sandler reiterated an “overweight” rating on shares of Billiontoone in a report on Wednesday, December 10th. Finally, Jefferies Financial Group began coverage on Billiontoone in a research note on Monday, December 1st. They issued a “hold” rating and a $117.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Billiontoone presently has a consensus rating of “Moderate Buy” and an average target price of $129.57.

Institutional Investors Weigh In On Billiontoone

Several institutional investors have recently added to or reduced their stakes in the business. Rossby Financial LCC purchased a new position in shares of Billiontoone in the fourth quarter worth about $25,000. Wells Fargo & Company MN bought a new position in Billiontoone in the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC purchased a new position in Billiontoone in the 4th quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P bought a new stake in Billiontoone during the 4th quarter valued at $82,000. Finally, Renaissance Capital LLC purchased a new stake in shares of Billiontoone during the fourth quarter worth $201,000.

Billiontoone Price Performance

The company has a fifty day simple moving average of $86.15. The company has a market capitalization of $3.32 billion and a PE ratio of 725.10.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.